CIK 0001826457 · last filing 3d ago · 12 insider transactions
Chief Medical Officer · sold $610.0K
Chief Operating Officer · sold $34.8K
Chief Scientific Officer · sold $41.6K
Proposed sale of 30,000 sh ($621.3K) · discretionary
Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 4d ago | FILIP JANKU Officer | 30,000 | $621.3K | Jun 24, 2026 | Exercise of Stock Options | Discretionary |
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
3d ago Jun 24, 2026 | Janku Filip Chief Medical Officer | Buy · M | 30,000 | $7.56 | $226.8K | Neutral0 | 10b5-1 | |
3d ago Jun 24, 2026 | Janku Filip Chief Medical Officer | Sell · S | 30,000 | $21.42 | $642.7K | Neutral0 | 10b5-1 | |
3d ago Jun 24, 2026 | Janku Filip Chief Medical Officer | Buy · M | 30,000 | $0.00 | $0 | Neutral0 | 10b5-1Deriv | |
3d ago Jun 23, 2026 | Champoux Jennifer Chief Operating Officer | Buy · M | 2,175 | $3.98 | $8.7K | Neutral+7 | 10b5-1 | |
3d ago Jun 23, 2026 | Champoux Jennifer Chief Operating Officer | Sell · S | 2,175 | $20.00 | $43.5K | Neutral+7 | 10b5-1 | |
3d ago Jun 23, 2026 | Champoux Jennifer Chief Operating Officer | Buy · M | 2,175 | $0.00 | $0 | Neutral+7 | 10b5-1Deriv | |
3d ago Jun 23, 2026 | Townson Sharon Chief Scientific Officer | Buy · M | 3,000 | $6.14 | $18.4K | Neutral+7 | 10b5-1 | |
3d ago Jun 23, 2026 | Townson Sharon Chief Scientific Officer | Sell · S | 3,000 | $20.00 | $60.0K | Neutral+7 | 10b5-1 | |
3d ago Jun 23, 2026 | Townson Sharon Chief Scientific Officer | Buy · M | 3,000 | $0.00 | $0 | Neutral+7 | 10b5-1Deriv | |
3d ago Jun 23, 2026 | Janku Filip Chief Medical Officer | Buy · M | 6,000 | $7.56 | $45.4K | Neutral0 | 10b5-1 | |
3d ago Jun 23, 2026 | Janku Filip Chief Medical Officer | Sell · S | 11,845 | $20.22 | $239.5K | Neutral0 | 10b5-1 | |
3d ago Jun 23, 2026 | Janku Filip Chief Medical Officer | Buy · M | 6,000 | $0.00 | $0 | Neutral0 | 10b5-1Deriv |
No strong cross-source signal right now. Form 144 shows $621.3K of planned insider selling and insiders are net sellers.
Convergence is a transparent heuristic sum of attributable disclosure factors — not a price target or recommendation. 8-K events are shown as context; Form 144 planned sales count against bullish conviction. Not financial advice.